DGS Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

DGS Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$338K	Buy
2024 Q3	$246K	Buy
2024 Q2	$207K	Buy
2024 Q1	$163K	Buy
2023 Q4	$119K	Buy
2023 Q2	–	Sell
2023 Q1	$124K	Sell
2022 Q4	$139K	Buy
2022 Q3	$88.2K	Buy
2022 Q2	–	Sell
2022 Q1	$147K	Buy